{
  "$schema": "folio-library-entry/v1",
  "id": "10665-371662",
  "blocks": [
    {
      "id": "library/10665-371662/blocks/prose-sec-front-matter",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Front matter",
      "pageStart": 1,
      "pageEnd": 8,
      "target": "../sections/sec-front-matter.md",
      "narrative": null,
      "content": "WHO/POLIO/23.02 \nPoliovirus containment \n \nGUIDANCE TO MINIMIZE RISKS FOR FACILITIES \nCOLLECTING, HANDLING OR STORING MATERIALS \nPOTENTIALLY INFECTIOUS FOR POLIOVIRUSES, \nSECOND EDITION \n \n \n \n \nWEB ANNEX A \nCOUNTRY- AND AREA-SPECIFIC POLIOVIRUS DATA, \nAPRIL 2023 UPDATE \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \nPoliovirus containment: guidance to minimize risks for facilities collecting, handling or storing materials potentially \ninfectious for polioviruses, second edition. Web Annex A. Country- and area-specific poliovirus data, April 2023 update \nWHO/POLIO/23.02 \n© World Health Organization 2023",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "The front matter of Web Annex A to WHO's poliovirus containment guidance, which gives country- and area-specific poliovirus data as of April 2023 (WHO/POLIO/23.02). It contains the title and copyright pages with the CC BY-NC-SA 3.0 IGO licence, a contents list and abbreviations. It then explains how the data table should be read, including how dates of wild and vaccine-derived poliovirus circulation and of oral polio vaccine use were recorded. Notes clarify which samples count as potentially infectious material for each virus type, and that the month of last trivalent OPV use was set to December where only the year was known.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-371662/blocks/prose-sec-000",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Table A2.1. Country- and area-specific poliovirus circulation data, April 2023 update",
      "pageStart": 8,
      "pageEnd": 29,
      "target": "../sections/sec-000-table-a21-country--and-area-specific-poliovirus.md",
      "narrative": null,
      "content": "Table A2.1. Country- and area-specific poliovirus circulation data, April 2023 \nupdate \n \nNo. \nCountry or area \n1. WPV/VDPV potentially infectious material dates \n2. OPV2/nOPV2/Sabin2 \npotentially infectious \nmaterial dates \n(Must mitigate now) \nWPV1/cVDPV1 \nWPV2/cVDPV2 \n(Must contain now) \nWPV3/cVDPV3 \n(Must contain now) \n \n1. \nAfghanistan1 \nEndemic (1) \n• Until Nov 1997 (2, 3) \n• Jun 2010 – Mar 2013 \n(1) \n• Jan 2020 – Jul 2021 \n(1) \nUntil Apr 2010 (1) \n• May 2010 \n• Apr 2013 – Jul 2016 \n• Aug 2021 – Mar 20222 \n \n2. \nAlbania1 \nUntil Nov 1996 (4) \nUntil Dec 1985 (5) \nUntil Dec 1978 (5) \nJan 19",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Table A2.1 lists, country by country from Afghanistan onwards, the periods when materials collected there may be potentially infectious for wild or circulating vaccine-derived polioviruses of types 1, 2 and 3. A further column gives the periods when samples may contain type 2 oral polio vaccine or Sabin2-related virus, which must be mitigated, while types 2 and 3 must be contained now. Footnotes explain special cases and territories listed under other countries. The table is followed by a long reference list of surveillance reports and studies on poliovirus circulation.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    }
  ]
}
